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Abstract With an ageing global population, there is an urgent need to identify effective
strategies to maintain brain health across the life course and therein minimise the
risk of age-related neurodegenerative disorders reaching a severe stage which may
manifest as dementia. An increasing body of evidence indicates that nutrition is a
modifiable lifestyle factor that can promote healthy brain ageing and reduce
dementia risk. However, at present, little is known about which dietary patterns,
foods and food bioactives influence brain function during ageing, and more
research is required to identify at-risk individuals and population subgroups who
are most likely to benefit from future nutritional intervention intended to
promote healthier brain ageing. This article introduces the newly established
Medical Research Council-funded NuBrain consortium, the vision of which is to
provide a step change in research in the area by developing novel approaches and
techniques to further understand the complex interactions between diet and brain
health and how we can support appropriate behaviour changes in the population.
NuBrain will form a new, sustainable and internationally field-leading research
consortium with multidisciplinary and complementary areas of expertise to
address the fundamental research challenges in this area.
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Introduction
Globally, the number of people aged 60 years and
over is set to reach two billion by 2050 (Prince et al.
2015). As older people account for the majority of
health and social services spending, an increasing pop-
ulation share will result in greater demand on services
if not mitigated by healthy ageing (Beard & Bloom
2015). In recognition, the World Health Organization
(WHO) has highlighted ‘Ageing Well’ as a priority
public health message, whilst UK research bodies
including the Medical Research Council (MRC), the
National Institute for Health Research (NIHR) and
UK Research and Innovation (UKRI) have identified
healthy ageing as a priority research area.
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In most people, cognitive function – particularly
aspects of memory, executive function, processing
speed and reasoning – declines with age. However, in
some people these declines can be accelerated by the
presence of neurodegenerative brain diseases, such as
Alzheimer’s disease, which can progress to differing
degrees of cognitive impairment or to dementia (Deary
et al. 2009). It is now known that these neurodegener-
ative brain diseases start in midlife due to a host of
genetic, lifestyle and environmental factors (Ritchie
et al. 2015). Currently, dementia affects around
850 000 individuals in the UK and 47 million people
worldwide, with an estimated annual global cost of
approximately US$1 trillion (Prince et al. 2015). How-
ever, without intervention, dementia prevalence is pro-
jected to more than double by 2050, and the
worldwide cost of dementia is anticipated to reach US
$2 trillion by 2030 (Prince et al. 2015), placing a con-
siderable burden on individuals, families and public
health services (Livingston et al. 2017). Against this
background, there is an urgent need to identify (1) at-
risk individuals and (2) modifiable factors applied at
critical periods across the life course for targeted inter-
ventions to support better brain health in our ageing
population.
There is strong and growing evidence that nutrition
throughout the life course has a profound impact on
age-associated cognitive decline and represents a tract-
able target to modify individual cognitive health and
population dementia burden (Scarmeas et al. 2018).
However, more research is needed to understand fully
which dietary patterns, foods and food bioactives
influence brain function during ageing and, therefore,
have potential for preventing, delaying or attenuating
the neuropathological changes that can lead to demen-
tia. In the MRC/NIHR Review of Nutrition and
Human Health Research (MRC & NIHR 2017), the
role of nutrition in brain development and ageing was
highlighted as a target area to further understand how
nutrition can support good cognitive function and
mental wellbeing and maintain this into later life.
Although there are several ongoing brain health initia-
tives (e.g. EU Joint Programme – Neurodegenerative
Disease Research, EU Human Brian Project, US
BRAIN Initiative, China Brain Project), none have
nutrition at the centre of their research efforts. The
vision of the NuBrain consortium is to provide a step
change in research in the area by developing novel
approaches and techniques to further understand the
complex interactions between diet and brain health
and how we can support appropriate behaviour
change in the population. NuBrain will bring together
a new research consortium with multidisciplinary and
complementary areas of expertise to address this speci-
fic challenge. The aim is to build a sustainable, inter-
nationally field-leading consortium in nutrition and
brain health which can collectively address the funda-
mental research challenges in this area.
Nutrition and healthy brain ageing
Nutrition has emerged as a modifiable lifestyle factor
to promote healthy brain ageing and reduce dementia
risk (Livingston et al. 2017). Current evidence, which
is principally derived from observational studies, has
identified numerous dietary factors associated with
better cognitive performance, with cell and mouse
models providing insights into underlying physiologi-
cal and molecular mechanisms (Vauzour et al. 2017;
Scarmeas et al. 2018). Nutritional compounds which
have attracted attention for their potential to improve
cognition include the n-3 fatty acid, docosahexaenoic
acid (DHA) (Dyall 2015), B vitamins (Luchsinger
et al. 2007; Lefevre-Arbogast et al. 2016), plant-
derived flavonoids (Commenges et al. 2000; Letenneur
et al. 2007), vitamin D (Anastasiou et al. 2014) and,
inconsistently, inorganic nitrate (Gilchrist et al. 2014;
Shannon et al. 2017; Clifford et al. 2019). However,
comprehensive longitudinal data, combining sensitive
neural biomarkers (e.g. cognitive function, structural
and metabolic neuroimaging and fluid samples) with
state-of-the-art detailed nutrition profiling, are lacking.
Such information is needed to gain insights at a mech-
anistic level to inform decisions about which nutri-
tional interventions are likely to be most important at
both a population and individual level as either risk or
resilience factors for neurodegeneration and brain
health, respectively. It is also important to understand
the likely ‘effect-size’ to drive impact, as well as when
in the life course such nutrition-disease interactions
occur (either as risks or mitigations). It is proposed
that the greatest benefits of better nutrition will be to
mitigate the high risk of brain disease in subgroups,
such as those with an APOEe4 genotype, females or
those with a high cardiovascular burden (who experi-
ence earlier dementia onset, lower disability-free life
expectancy and high lifetime health and social care
costs; Pontifex et al. 2018). However, associations
between nutrition and brain health for other, perhaps
more prevalent, population subgroups are not fully
defined and are a research priority.
Unsurprisingly, given the likely additive or synergis-
tic effect of individual foods and dietary compounds,
specific dietary patterns modelled on the traditional
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such as the Mediterranean diet (MedDiet) – which has
long been considered a paragon of healthy eating –
have emerged as being potentially effective at main-
taining brain health during ageing (Petersson & Philip-
pou 2016). The dietary pattern these days described as
the MedDiet is a primarily plant-based dietary pattern,
incorporating a high consumption of fruits, vegetables,
legumes, nuts, seeds and unrefined grains. Fish is typi-
cally consumed in moderate amounts, whilst red meat,
processed foods and sugar-sweetened products are
consumed sparingly. In addition, olive oil is used as a
principal cooking fat, whilst alcohol (typically red
wine) is consumed in small-to-moderate amounts, usu-
ally as an accompaniment to meals (Bach-Faig et al.
2011). In observational studies, conducted mainly in
the Mediterranean basin, high versus low adherence to
a MedDiet has been associated consistently with
improved cognition, reduced cortical atrophy (the
gradual and progressive degeneration of the outer
layer of the brain) and a 10–40% lower incidence of
dementia (Petersson & Philippou 2016). In addition,
results from the Navarra and Barcelona cohorts of the
Prevencion con Dieta Mediterranea (PREDIMED)
randomised controlled trial (RCT) demonstrate that
intervention with a MedDiet, which in this study was
supplemented with additional extra virgin olive oil or
nuts, can improve cognition and reduce the rate of
cognitive decline (Martınez-Lapiscina et al. 2013,
2014; Valls-Pedret et al. 2015). Outside the Mediter-
ranean basin, fewer studies have explored associations
between MedDiet adherence and cognitive function or
dementia risk. However, promisingly, recent analyses
of the UK-based Lothian Birth Cohort (Corley et al.
2013; Luciano et al. 2017) and EPIC-Norfolk Cohort
(Shannon et al. 2019) have demonstrated that higher
adherence to the MedDiet is associated with reduced
brain atrophy and better cognitive function across sev-
eral domains. This suggests that, with correct imple-
mentation, the MedDiet could represent an effective
dietary strategy to aid healthy brain ageing in non-
Mediterranean countries such as the UK. Mechanisti-
cally, these effects may be related to favourable alter-
ations in blood glucose and lipid profiles (Rodrıguez-
Rejon et al. 2014; Ros et al. 2014), decreased oxida-
tive stress and inflammation (Mena et al. 2009;
Urquiaga et al. 2010; Casas et al. 2014), augmented
nitric oxide (NO) bioavailability (Siervo et al. 2018;
Shannon et al. 2018) and modulation of the gut
microbiome (Filippis et al. 2016; Tosti et al. 2018). In
NuBrain, we will extend these encouraging initial find-
ings using data from other large UK cohorts as out-
lined below (see Work Package 2).
In addition to poor nutrition, physical inactivity has
emerged as an important determinant of cognitive
function and accounts for approximately 20% of the
population attributable risk (PARs) of Alzheimer’s
dementia in the UK and in other European and US
populations (Norton et al. 2014). Together, physical
inactivity and poor diets have been estimated to
account for ~50% of Alzheimer’s disease cases that
can be attributed to modifiable risk factors (Norton
et al. 2014). As the effects of diet and physical activity
on cognitive health are likely to be additive, multi-do-
main interventions that include both of these elements
have attracted attention in recent years. Of particular
importance is the Finnish Geriatric Intervention Study
to Prevent Cognitive Impairment and Disability (FIN-
GER) trial (Ngandu et al. 2015), which assessed the
cognitive effect of a diet based on Finnish nutrition
recommendations, alongside exercise, cognitive train-
ing and monitoring of vascular risk in an ‘at-risk’
elderly Finnish cohort. Following a 2-year interven-
tion period, cognitive performance, as assessed
through the comprehensive neuropsychological test
battery (NTB), was improved compared with control
(Ngandu et al. 2015). The effects of a combined diet-
ary and physical activity intervention for dementia
risk reduction in a UK setting are currently being
explored as part of the ongoing MedEx Dementia
Risk Reduction-UK programme (MedEx_DRRUK
2017) with initial feasibility data collection due to be
completed in 2020. This is discussed in more detail
below (see Work Package 3).
The NuBrain consortium
The NuBrain consortium has been funded by the
MRC UK Nutrition Research Partnership (NRP) Col-
laboration Award. The consortium will aim to address
the challenge of optimal nutrition for healthy brain
ageing through a number of key objectives. These
objectives will be addressed through five work pack-
ages that include activities and feasibility studies utilis-
ing novel approaches and multidisciplinary expertise.
By focussing on these objectives, the consortium will
work collaboratively to advance understanding of the
complex interactions between nutrition and brain
health during ageing and to develop and test interven-
tions to achieve behaviour change in individuals, in
order to manifest substantial impact at the population
level. The objectives of the collaboration are to:
(1) Create a strong, sustainable multidisciplinary UK
collaboration and Virtual Centre of Excellence,
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focussed on strengthening and developing nutri-
tion and brain ageing research.
(2) Provide a supportive and open environment for
early and mid-career researchers from multiple
disciplines to develop new skills and expertise and
to foster innovation in nutrition and brain ageing
research.
(3) Utilise existing cohort data sets and new data col-
lected using state-of-the-art biomarker and beha-
viour (in particular nutritional) capture
approaches to identify the biological mechanisms
underpinning potentially effective and specific
nutritional and other lifestyle interventions for
healthy brain ageing.
(4) Develop and validate tools for early identification
of at-risk individuals and population subgroups
who are most likely to benefit from future nutri-
tional interventions intended to promote healthier
brain ageing and reduce the population burden of
dementias.
(5) Begin to explore the aetiology of cognitive decline
and higher dementia burden in females with a
view to developing sex-specific diagnostic
approaches and effective nutrition interventions to
mitigate this.
(6) Prepare to coordinate the implementation of the
first large-scale, definitive UK intervention study
(MedEx) to test the hypothesis that ‘whole diet’
interventions can prevent/delay cognitive loss and
reduce dementia risk during ageing.
(7) Work with the UK food industry and retail, public
health, government, charities and members of the
public to explore translational approaches to
behaviour change in food production, purchas-
ing and consumption to promote healthy brain
ageing.
(8) Disseminate key findings and outcomes of the col-
laboration to the academic community and other
stakeholders, and encourage further multidisci-
plinary/cross-boundary research.
Work Package 1: Collaboration launch and
consortium development
The first work package of NuBrain will focus on gov-
ernance and the launch of the NuBrain collaboration.
This will include establishment of the collaboration’s
Executive and Steering Group, and a range of launch
events at different institutions for academics and
industry partners. We will also arrange a half-day
public engagement event in collaboration with VOICE
(www.voice-global.org/), an organisation that aims to
capture the public’s experience, ideas, opinions and
expectations about research, innovation and policy
developments that affect their lives. Collectively, these
activities will allow the collaboration to develop new
ideas, encourage new players to engage with the col-
laboration, raise the profile of the initiative, inform
the public of the current state of knowledge and
gain valuable public perception and insight to help
inform future research in the area. The consortium
will also set up a NuBrain website to communicate
the main aims, objectives, events and new findings of
the collaboration.
As part of Work Package 1, the consortium will
host a sandpit event for early career researchers
(ECRs) to develop new ideas and approaches. Senior
academics and representatives from industry, charity
sector and public health will provide guidance and
mentorship to the ECRs throughout the event lead-
ing to further mentoring opportunities for fellowship
applications or inclusion on bids. The sandpit event
(due to take place late 2020) will provide a support-
ive environment to encourage the development of
novel pilot/feasibility study proposals in nutrition
and brain ageing led by ECRs. Successful proposals
will be funded by the NuBrain consortium for
12 months.
Work Package 2: Nutrition and brain ageing cohort
analysis
This work package aims to utilise and improve the
linkage between key platforms and cohorts, and to
develop deeper phenotyping to understand better the
potentially effective dietary and lifestyle interven-
tions for healthy brain ageing in different target
populations.
Epidemiological and clinical trial evidence has indi-
cated a role for diet in both the increase and decrease
of incident dementia, as well as the amelioration of
the course of disease in the period before dementia
onset (Livingston et al. 2017; Scarmeas et al. 2018).
Study conclusions are not consistent however, perhaps
because diet is a complex interplay of multiple nutri-
tional components that may have differential effects
on brain health at different time points in the life
course of the individual and life cycle of neurodegen-
erative disease. A much clearer understanding of the
mechanisms linking specific nutritional exposures and
markers of neuronal and synaptic health is required to
provide an empirical basis for further interventions,
either at a public health or individual level, as part of
a personal prevention plan.
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We have direct access to the full data sets for Euro-
pean Prevention of Alzheimer’s Dementia Consortium
(EPAD) (Ritchie et al. 2016; Solomon et al. 2018) and
PREVENT Dementia (Ritchie & Ritchie 2012). In
each, there is detailed phenotyping of neurodegenera-
tive biomarkers and nutritional status, with a com-
bined sample size of over 3000 individuals (none with
dementia at baseline), aged 40–90 years. Discoveries
of mechanisms linking specific nutritional elements to
markers of neurodegeneration can then be used as the
basis for informed enquiry about links between diets
containing these elements and the same markers in
other data sets such as UK Biobank. The heterogeneity
of the cohorts we will have access to in fact helps sup-
port understanding whether consistency is present. For
example, establishing whether findings are replicated
between different heterogeneous data sets will allow
us to generate hypotheses about reasons for consis-
tency or inconsistency of findings including differences
in design and data. Further, the analyses of multiple
cohorts, particularly when these are large and are
heterogeneous such as EPAD (currently nine countries
involved including several in the Mediterranean
region) and UK Biobank, provide opportunities for
subgroup investigations that may be informative for
the identification of specific subgroups or life course
stages where associations may operate differently. One
critical line of enquiry is whether observations of an
association between diet and nutrition and brain
health in epidemiological studies are a direct effect on
the brain or a downstream consequence of improve-
ments in cardiovascular and cerebrovascular health or
an effect on the metabolic syndrome and diabetes.
Access to longitudinal data sets purposed specifically
to look at brain changes that also contain extensive
lifestyle and nutritional analysis (as well as potential
confounders) will help address this question.
Work Package 3: Future development of nutrition
and brain ageing interventions
The ongoing MedEx_DRRUK programme aims to
conduct the first large scale UK-based dementia risk
reduction RCT, establishing whether a behavioural
intervention over 2–5 years, to promote a MedDiet
with or without increased physical activity, can reduce
cognitive decline and brain atrophy in ‘at-risk’ adults
(Bundy & Minihane 2018). As part of phase 1 of the
MedEx_DRRUK, which was funded by Alzheimer’s
Research UK, we are conducting the MedEx1 feasibil-
ity study in three UK centres (Norwich, Birmingham
and Newcastle). This 6-month trial with older, UK
adults aged 55–74 years will investigate the feasibility
of achieving behaviour change in a UK population ‘at
risk’ of dementia. The intervention is delivered using
an interactive web-based intervention on the ‘Lifestyle,
Eating, Activity and Planning’ (LEAP2) platform, plus
food delivery and face-to-face group-based sessions.
The primary outcome measures are feasibility and
behavioural change in response to the interventions,
evaluated by participant recruitment and retention on
the trial, and changes in MedDiet Score and physical
activity. Secondary outcomes (used to inform the
design and powering of a main trial) are cognitive test
performance (assessed on measures of global and
domain-specific function, including memory and non-
memory performance), neuroimaging (MRI to assess
regional blood flow) and the QRISK2 score (calculated
using demographic and clinical information including
blood pressure, cholesterol concentration, body mass
index and disease history; https://qrisk.org/2017/). In
NuBrain, we will conduct MedEx2 piloting and feasi-
bility studies to inform future large scale interventions
in this area.
Work Package 4: Industry, public health and policy
engagement
Work Package 4 will organise workshops and focus
groups with industry, food retailers, public sector
organisations and local authorities to explore opportu-
nities to develop translational approaches to encour-
age new product development and behaviour change
in food purchasing and consumption to promote
healthy brain ageing. As part of this work package,
we will also develop links with policy makers and
implementers.
Work Package 5: Dissemination, communication of
collaborative activities and development of further
funding bids
Work Package 5 will develop a range of dissemination
and knowledge transfer activities with key stakehold-
ers to share the outcomes from the NuBrain collabora-
tion. This is of vital importance to maintain the
profile of the consortium, inform future potential bids
and to continue to attract new players to the research
area. This will include the final annual meeting of the
collaboration, the development of a toolkit of
resources for public engagement and an industry-fac-
ing workshop in collaboration with Campden BRI.
Importantly, we shall also use the knowledge and find-
ings developed from the previous work packages to
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design and prepare funding bids for future pragmatic
and scalable nutritional interventions to test potential
dietary interventions to maintain good brain health
during ageing.
Conclusions
The NuBrain consortium will build a sustainable,
internationally field-leading consortium in nutrition
and brain ageing. The consortium will work collabo-
ratively to advance understanding of the complex
interactions between nutrition and brain health during
ageing, and will develop and test interventions to
achieve positive behaviour change that facilitates
healthy brain ageing. Given the rapidly increasing
prevalence and escalating cost of dementia and other
age-related cognitive disorders, this work is urgently
needed. The consortium welcomes new collaborators
in any relevant field and should contact the authors of
this paper for further information on collaborative
opportunities.
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